Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases
Funds foreign and domestic entities running rare-disease clinical trials through FDA orphan products research grants.
The Food and Drug Administration administers this grant through the Office of Orphan Products Development rare disease research grant programs. The R01 notice funds clinical trials of orphan products that evaluate efficacy or safety for a new indication or labeling change addressing unmet needs in rare diseases or conditions.
Foreign or domestic public or private for-profit and nonprofit entities…
Clinical trials evaluating efficacy or safety of medical products for new indications or labeling changes addressing unmet needs in rare diseases.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Sign up free to see where teams trip up